MOLECULIN BIOTECH INC (MBRX)
US60855D3098 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 23.55M | 43.15M | 70.90M | 15.17M | 10.74M | |||
| Receivables | 1.52M | 1.05M | 500.00K | 160.00K | 10.00K | |||
| Other Current Assets | 1.20M | 1.40M | 1.10M | 1.86M | 2.74M | |||
| Total Current Assets | 26.27M | 45.60M | 72.50M | 17.20M | 13.48M | |||
| Non-Current Assets | ||||||||
| PPE Net | 796.00K | 680.00K | 450.00K | 690.00K | 600.00K | |||
| Intangibles | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | |||
| Total Non-Current Assets | 11.94M | 11.82M | 11.59M | 11.83M | 11.76M | |||
| TOTAL ASSETS | 38.22M | 57.42M | 84.09M | 29.03M | 25.24M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 4.26M | 2.64M | 2.15M | 1.71M | 1.32M | |||
| Accounts Payable | 2.50M | 2.10M | 1.36M | 1.13M | 2.15M | |||
| Other Current Liabilities | 60.00K | 90.00K | 110.00K | 80.00K | 100.00K | |||
| Total Current Liabilities | 6.82M | 4.82M | 3.62M | 2.92M | 3.57M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 5.33M | 410.00K | 1.48M | 8.35M | 6.09M | |||
| Total Non-Current Liabilities | 5.33M | 410.00K | 1.48M | 8.35M | 6.09M | |||
| TOTAL LIABILITIES | 12.14M | 5.23M | 5.10M | 11.27M | 9.66M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -131.60M | -101.84M | -72.81M | -56.92M | -39.56M | |||
| Additional Paid In Capital | 157.65M | 153.99M | 151.73M | 74.67M | 55.06M | |||
| Common Shares | 33.00K | 30.00K | 30.00K | 70.00K | 50.00K | |||
| Other Shareholders' Equity | -9.00K | 10.00K | 40.00K | -60.00K | 30.00K | |||
| Shares Outstanding | 2.23M | 28.63M | 28.58M | 11.54M | 7.62M | |||
| Tangible Book Value per Share | 6.70 | 1.43 | 2.37 | 0.57 | 0.58 | |||
| Total Shareholders' Equity | 26.07M | 52.19M | 78.99M | 17.76M | 15.57M | |||
| TOTAL LIABILITIES AND EQUITY | 38.22M | 57.42M | 84.09M | 29.03M | 25.24M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 3.86 | 9.46 | 20.03 | 5.89 | 3.78 | |||
| Return On Assets (ROA) | -77.89% | -50.56% | -18.90% | -59.80% | -52.34% | |||
| Return On Equity (ROE) | -114.18% | -55.62% | -20.12% | -97.75% | -84.84% | |||
All data in USD